Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

Ramsay deal may unblock

Media reports suggest that Ramsay Santé, the 53%-owned continental European arm of Ramsay Health Care, may relent and allow KKR to carry out due diligence which would enable it to complete on its AU$88 a share bid. But investors were not convinced with the shares languishing at AU$69.84 at close of play.

German hospital sector faces cliff

The number of hospitals losing money will more than double to 59% in 2022 and the situation is likely to get far worse as the Covid block payment comfort cushion has been removed. Meanwhile, statutory insurers face huge deficits, hospital productivity is falling and vacancies increasing. The annual 2022 hospital rating report from the Leibniz Institute of Economic Research and the Institute for Healthcare Business paints a truly dire picture.

Bid may undervalue Mediclinic

South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.

Portuguese hospital groups face €191 million fine

The Autorldade da Concorrencia (AdC), the Portuguese Competition Authority, has sanctioned and imposed fines of €191 million on several private hospital groups and the Portuguese Private Hospitals Association (APHP).

Vivalto Sante goes international with expansion into Portugal and Switzerland

Vivalto Sante, the third largest for-profit hospital group in France, is joining the likes of Fresenius, Ramsay and Mediclinic as it becomes the latest member of the highly select club of multinational hospital groups. As well as having bought a chain of three clinics in Switzerland, it is buying Lusiadas Saude, the third largest hospital group in Portugal. CEO Daniel Caille tells HBI that the decision to go international has nothing to do with opportunities for consolidation within the French market drying up.

Going international is hard for hospital groups

Vivalto Sante has taken the brave step of going international. That is a bold decision for a hospital business based in a single European country. Very few have succeeded in doing this and those that have are top players buying top players. We think of Fresenius Helios buying Quiron in Spain, Ramsay buying Generale de Santé in France and then Capio in Sweden, and Mediclinic buying Hirslanden in Switzerland. 

Swiss labs suffer 10% cut, more may follow

Switzerland has chopped its diagnostic lab prices by 10% in a move that is billed as saving CHf 140m (€141). There could well be further crackdowns following a publication highlighting the massive differences between Swiss prices and those in France, Germany and the Netherlands.

Find Us